STEVEN M. HAMILL is a Vice President and Senior Research Analyst at
U.S. Bancorp Piper Jaffray, covering diagnostics and blood management
and safety. Before joining U.S. Bancorp Piper Jaffray in July 2003, he
was a Senior Research Analyst at RBC Capital Markets in Minneapolis,
where he also covered medical device companies. Prior to working on Wall
Street, he was a manager in the Business Valuation Practice for Arthur
Andersen LLP in Minneapolis and Milwaukee, for more than seven years. He
graduated from Marquette University in Milwaukee, magna cum laude, with
Bachelor of Science degrees in Economics and Finance. He holds the
Chartered Financial Analyst designation and is a member of the
Association for Investment Management and Research.
In-vitro Diagnostics: Steven Hamill - U.s. Bancorp Piper Jaffray Inc
November 24, 2003